Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Mirjana Jarebinski"'
Autor:
Ljiljana Beslac Bumbasirevic, Tatjana Pekmezovic, Mirjana Jarebinski, Milica Kostic, Darija Kisic Tepavcevic
Publikováno v:
Clinical Neurology and Neurosurgery. 110:51-57
Objective To estimate trends in mortality due to different stroke subtypes in the population of Belgrade during the period 1989–2003. Patients and methods Mortality data for stroke were compiled from material of the Municipal Institute of Statistic
Autor:
Milica Kostic, Mirjana Jarebinski, Ljiljana Beslac Bumbasirevic, Tatjana Pekmezovic, Darija Kisic Tepavcevic
Publikováno v:
Cerebrovascular Diseases. 24:191-195
Objective: To assess the age, period, and cohort effects on stroke mortality in Belgrade, Serbia, between 1989 and 2003. Methods: Mortality data for stroke events were obtained from the Municipal Institute of Statistics. The age- and gender-specific
Autor:
Henry Dushan Atkinson, Mirjana Jarebinski, Dusko Spasovski, Aleksandar Lesic, M. Bumbasirevic, Tatjana Pekmezovic
Publikováno v:
Archives of Orthopaedic and Trauma Surgery. 127:179-183
This study retrospectively determined the incidence rates of hip fractures in Belgrade, Serbia and Montenegro, during the period 1990–2000. All patients with hip fractures treated at all Belgrade hospitals were identified from the Republic of Serbi
Autor:
Nebojsa Stojsavljevic, Jelena Drulovic, Jelena Kostic, Sarlota Mesaros, Darija Kisic, Marija Milenkovic, Mirjana Jarebinski, Tatjana Pekmezovic
Publikováno v:
Neuroepidemiology. 27:212-216
The aim of this case-control study was to assess the risk of developing multiple sclerosis (MS) associated with certain lifestyle factors (cigarette smoking and coffee and alcohol consumption). The study groups consisted of 210 cases with clinically
Publikováno v:
Acta chirurgica Iugoslavica. 52:95-99
The aim of this survey was estimation of incidence of hip fractures in the population of Belgrade during the period from 1990 to 2000, as well as the estimation of expected numbers and incidence of hip fractures for 2010 and 2020, based on linear tre
Publikováno v:
Vojnosanitetski Pregled, Vol 61, Iss 3, Pp 267-272 (2004)
Data about mortality from malignant tumors of endometrium were analyzed in the Belgrade area during the period 1975-2000. The obtained results showed that the average percentage of endometrial cancer in mortality structure from all the cancers of fem
Autor:
Ivan Boricic, Tatjana Pekmezovic, Mirjana Jarebinski, Zorana Gledovic, Dragan Delic, Milena Kanazir
Publikováno v:
Acta chirurgica Iugoslavica. 51:105-110
The aim of this analysis was to estimate death rates for primary liver cancer (PLC) and their secular trends in the population of Belgrade during the period 1982-2001. Mortality data (number of deaths caused by PLC) in Belgrade were obtained from the
Autor:
M Branko Vujkovic, D Tatjana Pekmezovic, Anita Knezevic, Darija Kisic, S Mirjana Jarebinski, R Marina Nikitovic, Milen Pavlovic
Publikováno v:
Vojnosanitetski Pregled, Vol 60, Iss 5, Pp 565-568 (2003)
Background. The aim of this investigation was the analysis of primary malignant brain tumors (PMBT)-related mortality in the Belgrade population during the period 1983?2000. Methods. Mortality data (based on death records) for the period observed, as
Autor:
Jelena Drulovic, Nebojsa Stojsavljevic, Tatjana Pekmezovic, Sarlota Mesaros, Dusan Popadic, Irena Dujmovic, Vera Pravica, Mirjana Jarebinski, Gradimir Bogdanović, Ivana Cvetkovic, Djordje Miljković, Marija Mostarica Stojković
Publikováno v:
European Neurology. 50:25-29
Tumor necrosis factor (TNF) alpha has been considered the prototypic cytopathogenic cytokine in multiple sclerosis (MS), but recently this cytokine has been shown to possess significant anti-inflammatory and neuroprotective effects in demyelinating d
Autor:
Mirjana Jarebinski, Zvonimir Lević, Jelena Drulovic, Tatjana Pekmezovic, Nebojsa Stojsavljevic
Publikováno v:
Neuroepidemiology. 21:235-240
The aim of this study was to estimate survival rates of multiple sclerosis (MS) patients in the Belgrade population, Yugoslavia, and furthermore, to determine the prognostic value of some demographic and clinical variables for survival. The cumulativ